Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C

Journal of Biomedical Science

Volumn 5, Issue 4, 1998, Pages 290-296

  Chiang, Bor Luen ^a   Yang, Pei Ming ^a   Hwang, Lih Hwa ^b   Wang, Jo Man ^a   Kao, Shing Fen ^a   Pan, Chien Hsiung ^a   Chi, Wei Kuang ^c   Chen, Pei Jer ^a   Chen, Ding Shinn ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytokines; Hepatitis C virus; T cell clones

Indexed keywords

ADULT; ANTIGENICITY; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CHRONIC HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 84984585951     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255861     Document Type: Article

References (29)

1. Alter HJ, The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol 1(suppl):78-94; 1990.
2. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 67:3835-3844;1993.
3. Bertoletti A, Sette A, Chisari FV, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410;1994.
4. Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Current Opin Immunol 6:530-538; 1994.
5. Botarelli P, Brunetto MR, Miuntello MA, et al. T-lymphocyte response to hepatitis C virus in different clinical course of infection. Gastroenterofogy 104:580-587;1993.
6. Chen D-S, Kuo G, Sung J-L, et al. Hepatitis C virus infection in the area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162:817-822; 1990.
7. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, nonB viral hepatitis genome. Science 244:359-362; 1989.
8. Chromczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159;1987.
9. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency vinis-seropositive individuals. J Clin Invest 91:759-765;1993.
10. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575-581;1994.
11. Diepolder HM, Zachoval R, Hoffmann RM. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007;1995.
12. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140;1992.
13. Ferrari C, Valli A, Galati L, et al. T-cell response to structural and nonstructural hepatitis C virus antigenic in persistent and self-limited hepatitis C virus infection. Hepatology 19: 286-295;1994.
14. Hwang L-H, Yang P-M, Lai M-Y, et al. Identification of humoral antigenic determinants within the hepatitis C virus NS3 protein. J Infect Dis 174:173-176;1996.
15. Koziel MJ, Dudely D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344;1992.
16. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364;1989.
17. Miyamura T, Saito I, Katayama S, et al. Detection of antibody against antigen expressed by molecularty cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87:983-987;1990.
18. Mosely JW, Aach RD, Hollinger FB, et al. Non-A, non-B hepatitis and antibody to hepatitis C virus. J Am Med Assoc 263:77-78;1990.
19. Nakatsuji Y, Matsumoto A, Tanaka E, et al. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16:300-305;1992.
20. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462-5466; 1991.
21. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679;1992.
22. Okamoto H, Kurai K, Okada S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188:331-341;1992.
23. Powrie F, Mason D. Phenotypic and functional heterogeneity of CD4+ T cells. Immunol Today 9:274-277;1988.
24. Reed SG, Scott P. T-cell and cytokine responses in leishmaniasis. Current Opin Immunol 5:524-531;1993.
25. Schupper H, Hayashi P, Scheffel J, et al. Peripheral-blood mononuclear cell response to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 18: 1055-1060,1993.
26. Shirai M, Okada H, Nishioka M. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68:3334-3342;1994.
27. Tomai L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017-4026;1993.
28. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA 89:3468-3472; 1992.
29. Yang P-M, Hwang L-H, Lai M-Y, et al. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant nonstructrual (NS3) protein of hepatitis virus in patients with chronic hepatitis C. Clin Exp Immunol 101:272-277;1995.